Mutations in MCT8 in patients with Allan-Herndon-Dudley-Syndrome affecting its cellular distribution

Molecular Endocrinology

Volumn 27, Issue 5, 2013, Pages 801-813

  Kersseboom, Simone ^a   Kremers, Gert Jan ^a   Friesema, Edith C H ^a   Edward Visser, W ^a   Klootwijk, Wim ^a   Peeters, Robin P ^a   Visser, Theo J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 8; THYROXINE;

ALLAN HERNDON DUDLEY SYNDROME; ARTICLE; CELL MEMBRANE; CELL MOTILITY; CELL STRAIN COS1; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE CONSTRUCT; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC DISORDER; HORMONE TRANSPORT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RUMINANT STOMACH; THYROID HORMONE METABOLISM;

ANIMALS; BLOTTING, WESTERN; CELL EXTRACTS; CELL LINE; CELL SURVIVAL; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMANS; IODINE RADIOISOTOPES; MENTAL RETARDATION, X-LINKED; MICROSCOPY, CONFOCAL; MONOCARBOXYLIC ACID TRANSPORTERS; MUSCLE HYPOTONIA; MUSCULAR ATROPHY; MUTATION; PROTEIN TRANSPORT; THYROXINE; TRANSFECTION; TRIIODOTHYRONINE;

EID: 84876880669     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1356     Document Type: Article

References (33)

1. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem. 2003;278(41): 40128-40135.
2. Friesema EC, Jansen J, Heuer H, Trajkovic M, Bauer K, Visser TJ. Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8. Nat Clin Pract Endocrinol Metab. 2006;2(9):512-523.
3. Santisteban P, Bernal J. Thyroid development and effect on the nervous system. Rev Endocr Metab Disord. 2005;6(3):217-228.
4. Friesema EC, Grueters A, Biebermann H, et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet. 2004;364(9443):1435-1437.
5. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet. 2004;74(1):168-175.
6. Schwartz CE, May MM, Carpenter NJ, et al. Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet. 2005;77(1):41-53.
7. Frints SG, Lenzner S, Bauters M, et al. MCT8mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression. Eur J Hum Genet. 2008; 16(9):1029-1037.
8. Visser WE, Jansen J, Friesema EC, et al. Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations. Hum Mutat. 2009;30(1):29-38.
9. Jansen J, Friesema EC, Kester MH, Schwartz CE, Visser TJ. Genotype-phenotype relationship in patients with mutations in thyroid hormone transporter MCT8. Endocrinology. 2008;149(5):2184-2190.
10. Trajkovic M, Visser TJ, Mittag J, et al. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest. 2007;117(3):627-635.
11. Dumitrescu AM, Liao XH, Weiss RE, Millen K, Refetoff S. Tissuespecific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology. 2006; 147(9):4036-4043.
12. Wirth EK, Roth S, Blechschmidt C, et al. Neuronal 3α,3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J Neurosci. 2009;29(30):9439-9449.
13. Kinne A, Roth S, Biebermann H, Kohrle J, Gruters A, Schweizer U. Surface translocation and tri-iodothyronine uptake of mutant MCT8 proteins are cell type-dependent. J Mol Endocrinol. 2009; 43(6):263-271.
14. Mol JA, Visser TJ. Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology. 1985;117(1): 1-7.
15. Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH. Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Mol Endocrinol. 2006;20(11):2761-2772.
16. Visser WE, van Mullem AA, Jansen J, Visser TJ. The thyroid hormone transporters MCT8 and MCT10 transport the affinity-label N-bromoacetyl-[(125)I]T3 but are not modified by it. Mol Cell Endocrinol. 2011;337(1-2):96-100.
17. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol. 2008; 22(6):1357-1369.
18. Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7): 676-682.
19. Jansen J, Friesema EC, Kester MH, et al. Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine. J Clin Endocrinol Metab. 2007;92(6):2378-2381.
20. Kirk P, Wilson MC, Heddle C, et al. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J. 2000;19(15):3896-3904.
21. Philp NJ, Ochrietor JD, Rudoy C, Muramatsu T, Linser PJ. Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse. Invest Ophthalmol Vis Sci. 2003;44(3):1305-1311.
22. Castorino JJ, Gallagher-Colombo SM, Levin AV, et al. Juvenile cataract-associated mutation of solute carrier SLC16A12 impairs trafficking of the protein to the plasma membrane. Invest Ophthalmol Vis Sci. 2011;52(9):6774-6784.
23. Wilson MC, Meredith D, Fox JE, Manoharan C, Davies AJ, Halestrap AP. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem. 2005;280(29):27213-27221.
24. Visser WE, Philp NJ, van Dijk TB, et al. Evidence for a homodimeric structure of human monocarboxylate transporter 8. Endocrinology. 2009;150(11):5163-5170.
25. Smith VE, Read ML, Turnell AS, et al. PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8. Endocrinology. 2012;153(7):3526-3536.
26. Lukacs GL, Verkman AS. CFTR: folding, misfolding and correcting the DeltaF508 conformational defect. Trends Mol Med. 2012; 18(2):81-91.
27. Wilson MC, Meredith D, Halestrap AP. Fluorescence resonance energy transfer studies on the interaction between the lactate transporter MCT1 and CD147 provide information on the topology and stoichiometry of the complex in situ. J Biol Chem. 2002;277(5): 3666-3672.
28. Alkemade A, Friesema EC, Kalsbeek A, Swaab DF, Visser TJ, Fliers E. Expression of thyroid hormone transporters in the human hypothalamus. J Clin Endocrinol Metab. 2011;96(6):E967-971.
29. Vaurs-Barriere C, Deville M, Sarret C, et al. Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects. Ann Neurol. 2009;65(1):114-118.
30. Kakinuma H, Itoh M, Takahashi H. A novel mutation in the monocarboxylate transporter 8 gene in a boy with putamen lesions and low free T4 levels in cerebrospinal fluid. J Pediatr. 2005;147(4): 552-554.
31. Wood T, Hobson D, Browning B, et al. The utilization of T3/T4 screening of males with MR of unknown etiology to identify patients with Allan-Herndon-Dudley syndrome. Barcelona, Spain: European Human Genetics Conference meeting; 2008, Abstract C07.6.
32. Papadimitriou A, Dumitrescu AM, Papavasiliou A, Fretzayas A, Nicolaidou P, Refetoff S. A novel monocarboxylate transporter 8 gene mutation as a cause of severe neonatal hypotonia and developmental delay. Pediatrics. 2008;121(1):e199-202.
33. Friesema EC, Visser WE, Visser TJ. Genetics and phenomics of thyroid hormone transport by MCT8. Mol Cell Endocrinol. 2010; 322(1-2):107-113.